FCM
MYOK
Farallon Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,225,000
| Closed | -$167M | – | 160 |
|
|
2020
Q3 | $167M | Buy |
1,225,000
+350,000
| +40% | +$47.7M | 1.16% | 33 |
|
|
2020
Q2 | $84.5M | Buy |
875,000
+445,000
| +103% | +$43M | 0.68% | 42 |
|
|
2020
Q1 | $20.2M | Sell |
430,000
-1,620,000
| -79% | -$75.9M | 0.17% | 67 |
|
|
2019
Q4 | $149M | Buy |
2,050,000
+19,603
| +1% | +$1.43M | 1.01% | 30 |
|
|
2019
Q3 | $106M | Buy |
2,030,397
+30,397
| +2% | +$1.59M | 0.8% | 31 |
|
|
2019
Q2 | $100M | Buy |
2,000,000
+49,722
| +3% | +$2.49M | 0.65% | 33 |
|
|
2019
Q1 | $101M | Buy |
1,950,278
+350,000
| +22% | +$18.2M | 0.76% | 34 |
|
|
2018
Q4 | $78.2M | Buy |
1,600,278
+69,000
| +5% | +$3.37M | 0.57% | 35 |
|
|
2018
Q3 | $99.8M | Buy |
1,531,278
+50,000
| +3% | +$3.26M | 0.59% | 34 |
|
|
2018
Q2 | $73.5M | Buy |
1,481,278
+442,000
| +43% | +$21.9M | 0.45% | 41 |
|
|
2018
Q1 | $50.7M | Buy |
1,039,278
+175,546
| +20% | +$8.57M | 0.35% | 48 |
|
|
2017
Q4 | $36.4M | Buy |
863,732
+466,232
| +117% | +$19.6M | 0.3% | 44 |
|
|
2017
Q3 | $17M | Buy |
+397,500
| New | +$17M | 0.15% | 58 |
|